18 Nov 2021 - {{hitsCtrl.values.hits}}
From left: Flexicare Lanka General Manager Sanjeeva Jayasinghe, Flexicare Chairman Dr. Ghassem Poormand, Board of Investment of Sri Lanka Chairman Sanjaya Mohottala and Flexicare Managing Director Hash Poormand at Flexicare press conference held at Taj Samudra Hotel
Flexicare Lanka, a fully-owned subsidiary of Flexicare Group, UK, has set up a state-of-the-art modern manufacturing facility in Bandaragama, with a total investment of over US $ 15 million.
This is the first time in Sri Lanka’s history of manufacturing that such a state-of-the-art medical device production plant begins its operations in the country. With over 90 percent of the production intended for exports, Sri Lanka is placed on the global medical consumable devices production map for the first time.
Flexicare Lanka will be employing over 600 people as part of its first phase, as it gears up production from its current workforce of 150, with plans for a second expansion in due course.
“Flexicare has invested over US $ 15 million into this project to support the growing demand within the region for high-quality medical products. Not only the first medical devices manufacturer in Sri Lanka but working alongside with the BOI and government agencies, we are the first entity to have terminal ethylene oxide sterilisation technology introduced here, which allows us to produce sterile products for our clinical environments,” stated Flexicare Group Chairman Ghassem Poormand.
Additionally, Flexicare Group Managing Director Hash Poormand stated, “With the advent of the COVID-19 pandemic, there has been no more an important time that life sustaining and lifesaving products are made available and accessible for our patients. Flexicare Lanka has been instrumental in ensuring that urgent medical devices were delivered across the world.”
Flexicare is a privately owned leading designer, manufacturer and supplier of medical devices backed by over 30 years of experience in the healthcare sector. Headquartered in the UK, Flexicare has expanded its international reach to over 110 countries, supported by wholly-owned subsidiaries and scientific offices in the USA, South America, the Netherlands, Germany, Italy, Turkey, Jordan, Egypt, India, Sri Lanka, Malaysia, Korea, China, Japan and Australia.
17 Nov 2024 48 minute ago
17 Nov 2024 3 hours ago
17 Nov 2024 3 hours ago
17 Nov 2024 6 hours ago
17 Nov 2024 6 hours ago